Patent · US Active

Substituted imidazo[2,1-b]thiazole compounds and uses thereof

US7893069B2 · kind B2 · utility

3Cited by

0References

30Claims

0Family size

Assignee

Gruenenthal GmbH · DE

Inventors

Sven Kuehnert · Lehrte, DE
Saskia Zemolka · Aachen, DE
Michael Haurand · Aachen, DE
Klaus Schiene · Goldkronach, DE

Key dates

Filing date	Sep 9, 2008
Grant date	Feb 22, 2011
Priority date	—
Expiry date	Apr 2, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Substituted imidazo[2,1-b]thiazole compounds corresponding to formula I,a method for producing them, pharmaceutical compositions containing them, and the use thereof for regularing mGluR5 receptors, or for treating or inhibiting disorders or disease states at least partially mediated by mGluR5 receptor such as pain, anxiety attacks, drug or alcohol dependency, and others.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.